JNJ ApS: Financial statements 2025
CVR: 45307824
Source: annual report 2025, Danish Business Authority
03/01/2025 – 31/12/2025
JNJ ApS (CVR 45307824) has filed annual accounts for 2025. In 2025, the company reported a gross profit of DKK -1,921 and a net result of DKK -1,921. Equity in the 2025 report amounted to DKK 43,079. The solvency ratio was 100%.
- Gross Profit
- DKK -1,921
- Profit/Loss
- DKK -1,921
- Equity
- DKK 43,079
- Total Assets
- DKK 43,079
- Employees
- 0
Official annual report
How creditworthy is JNJ ApS?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2025
As of January 3, 2025, Nicolai Andreas Clausen is registered as director of JNJ ApS.
As of January 3, 2025, HEMACAPE ApS is registered as an owner of JNJ ApS with an ownership share of 33%.
As of January 3, 2025, Ranol ApS is registered as an owner of JNJ ApS with an ownership share of 33%.
As of January 3, 2025, EDV ApS is registered as an owner of JNJ ApS with an ownership share of 33%.
JNJ ApS was founded on January 3, 2025.
About JNJ ApS
JNJ ApS is a Danish company of the type Anpartsselskab based in Randers C, founded in 2025. The company is registered under the industry Ikke-finansielle holdingselskaber. The management consists of Nicolai Andreas Clausen. The company is owned by HEMACAPE ApS, Ranol ApS and EDV ApS. According to the 2025 annual report, the company had an average of 0 employees. In 2025, the company reported a gross profit of DKK -1,921 and a net result of DKK -1,921. Equity in the 2025 report amounted to DKK 43,079.